Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors
- Autores: Autenshlyus A.I.1,2, Brusentsov I.I.1,3, Marinkin I.O.1, Smirnova S.A.4, Rukavishnikov M.Y.4, Lyakhovich V.V.2
-
Afiliações:
- Ministry of Healthcare of the Russian Federation
- Research Institute of Molecular Biology and Biophysics
- Federal Research Center Institute of Cytology and Genetics, Siberian Branch
- JSC Vector-Best
- Edição: Volume 478, Nº 1 (2018)
- Páginas: 37-40
- Seção: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journals.rcsi.science/1607-6729/article/view/212098
- DOI: https://doi.org/10.1134/S1607672918010106
- ID: 212098
Citar
Resumo
The content of mRNA of the histidine-rich glycoprotein (HRG), a potential marker of malignant neoplasia, which can be used in differential diagnosis of breast tumors, was determined in 110 breast tumor biopsy samples. The presence of HRG mRNA did not depend on the cancer type, on the preoperative treatment or its absence, as well as on the tumor progression stage and the presence of metastases.
Sobre autores
A. Autenshlyus
Ministry of Healthcare of the Russian Federation; Research Institute of Molecular Biology and Biophysics
Autor responsável pela correspondência
Email: lpciip@211.ru
Rússia, Novosibirsk, 630091; Novosibirsk, 630117
I. Brusentsov
Ministry of Healthcare of the Russian Federation; Federal Research Center Institute of Cytology and Genetics, Siberian Branch
Email: lpciip@211.ru
Rússia, Novosibirsk, 630091; Novosibirsk, 630090
I. Marinkin
Ministry of Healthcare of the Russian Federation
Email: lpciip@211.ru
Rússia, Novosibirsk, 630091
S. Smirnova
JSC Vector-Best
Email: lpciip@211.ru
Rússia, Kol’tsovo, Novosibirsk oblast, 633159
M. Rukavishnikov
JSC Vector-Best
Email: lpciip@211.ru
Rússia, Kol’tsovo, Novosibirsk oblast, 633159
V. Lyakhovich
Research Institute of Molecular Biology and Biophysics
Email: lpciip@211.ru
Rússia, Novosibirsk, 630117
Arquivos suplementares
